Infinitus Health Care Lung Defence

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

quercetin, Quantity: 20 mg; Echinacea purpurea, Quantity: 55.6 mg (Equivalent: Echinacea purpurea, Qty 834 mg); ascorbic acid, Quantity: 33.34 mg; Morus alba, Quantity: 50 mg (Equivalent: Morus alba, Qty 400 mg); Platycodon grandiflorus, Quantity: 100 mg (Equivalent: Platycodon grandiflorus, Qty 1 g); Astragalus membranaceus, Quantity: 50 mg (Equivalent: Astragalus membranaceus, Qty 1.125 g)

Verfügbar ab:

Achieve Correctness (Australia) Company Proprietary Limited

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: magnesium stearate; colloidal anhydrous silica; povidone; Carnauba Wax; iron oxide black; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; hypromellose; iron oxide yellow; crospovidone; tartaric acid; macrogol 400; croscarmellose sodium; titanium dioxide; maltodextrin

Verabreichungsweg:

Oral

Anwendungsgebiete:

Antioxidant/Reduce free radicals formed in the body ; Traditionally used in Chinese medicine to disseminate/diffuse lungs/lung-qi ; Maintain/support immune system health ; Traditionally used in Western herbal medicine to Decrease/reduce/relieve common cold duration ; Traditionally used in Chinese medicine to Clear/expel/dissolve/resolve Phlegm ; Traditionally used in Western herbal medicine to Decrease/reduce/relieve symptoms of common cold ; Traditionally used in Chinese medicine to Maintain/support lung health

Produktbesonderheiten:

Visual Identification: ;

Berechtigungsstatus:

Listed

Berechtigungsdatum:

2020-07-28